Chemotherapy for Surgically Resected Intrahepatic CholangiocarcinomaJohn T. Miura, T. Clark Gamblin, Fabian M. Johnston et al.|Annals of Surgical Oncology|2015Cited by 97
Surgical resection versus ablation for hepatocellular carcinoma ≤ 3 cm: a population-based analysisJohn T. Miura, T. Clark Gamblin, Fabian M. Johnston et al.|HPB|2015Cited by 46
Is Radiotherapy Warranted Following Intrahepatic Cholangiocarcinoma Resection? The Impact of Surgical Margins and Lymph Node Status on SurvivalAbdulrahman Y. Hammad, T. Clark Gamblin, Nick G. Berger et al.|Annals of Surgical Oncology|2016Cited by 36
Primary Liver Cancer: An NCDB Analysis of Overall Survival and Margins After HepatectomyChristopher Coon, T. Clark Gamblin, Nicholas G. Berger et al.|Annals of Surgical Oncology|2019Cited by 11
Molecular profiling in gastric cancer: Examining potential targets for chemotherapyJohn T. Miura, T. Clark Gamblin, Fabian M. Johnston et al.|Journal of Surgical Oncology|2014Cited by 7